File(s) under permanent embargo
338 Screening, recruitment and baseline characteristics of the long-term evaluation of glucosamine sulphate (legs) study participants
journal contribution
posted on 2023-05-20, 09:25 authored by Fransen, M, Maria Agaliotis, Nairn, L, Votrubec, M, Bridgett, L, Woodward, MClinical trials evaluating potential ’disease-modifying’ agents for osteoarthritis are required to demonstrate both symptomatic and structural benefit. Ideally, to reduce ceiling or floor effects, study participants are required to have at least moderate pain, yet retain sufficient tibiofemoral joint space to allow the measurement of narrowing over time. To describe study recruitment procedures and baseline demographics of people with symptomatic knee osteoarthritis participating in the Long-term Evaluation of Glucosamine Sulphate (LEGS) study (NCT00513422).
History
Publication title
Osteoarthritis and CartilageVolume
18Issue
Supplement 2Pagination
S149-S150ISSN
1063-4584Department/School
Australian Institute of Health Service Management (AIHSM)Publisher
Elsevier LtdPlace of publication
United KingdomRights statement
Copyright 2010 Elsevier Ltd.Repository Status
- Restricted